-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

624.O4.6 624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological: Mature T-cell Malignancies: Clinical and Epidemiological

Symposia: Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, adult, epidemiology, Lymphomas, Translational Research, elderly, Clinical Research, health outcomes research, T Cell lymphoma, Diseases, Therapies, Immunotherapy, real-world evidence, Adverse Events, Lymphoid Malignancies, young adult , Monoclonal Antibody Therapy, Study Population, Human
Sunday, December 11, 2022: 4:30 PM-6:00 PM
393-396 (Ernest N. Morial Convention Center)
Moderators:
Bradley M. Haverkos, MD, MS, MPH, Ohio State University and Enrica Marchi, MD, PhD, University of Virginia
Disclosures:
Marchi: University of virginia: Patents & Royalties: 3062/170 PROV; Merck: Research Funding; Celgene/BMS: Research Funding; Astex Pharmaceuticals: Research Funding; Kyowa Kirin: Honoraria; Daiichi Sankyo: Other: Participation at advisory board; Kymera Therapeutics: Research Funding; Everest Clinical Research: Other: Data Safety Monitoring Commettee.
4:30 PM

Greg Hapgood, MD, PhD1*, Monica Civallero, PhD2*, Yana Stepanishyna, PhD3*, Julie M. Vose, MD, MBA4, Maria Elena Cabrera, MD5*, Ranjana H. Advani, MD6, Stefano A Pileri, MD7, Martina Manni, PhD8*, Steven M. Horwitz, MD9, Francine M. Foss, MD10, Felicitas Hitz, MD11*, John Radford, MD, FRCPath, FMedSci12*, Ivan Dlouhy, MD13*, Carlos S. Chiattone, MD, PhD14, Won-Seog Kim, MD, PhD15*, Tetiana Skrypets, MD16*, Arnon Nagler, MD17, Judith Trotman, FRACP18, Stefano Luminari, MD19 and Massimo Federico, MD20

1Princess Alexandra Hospital, Brisbane, QLD, Australia
2Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy
3Oncohematology, National Cancer Institute, Kyiv, Ukraine
4Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center - Fred and Pamela Buffett Cancer Center, Omaha, NE
5Hematology Department, Hospital del Salvador, Santiago, Chile
6Department of Medicine, Division of Oncology, Stanford University, Stanford, CA
7Hematopathology Division, IEO Istituto Europeo di Oncologia IRCCS, Milano, Italy
8CHIMOMO Department, University of Modena and Reggio Emilia, Modena, Italy
9Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
10Hematology, Yale Cancer Center, New Haven, CT
11Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
12Department of Medical Oncology, The University of Manchester, Manchester, United Kingdom
13Hematopathology Unit, Hospital Clínic, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CIBERONC, Universitat de Barcelona, Lisbon, Portugal
14Oncology Nucleus, Samaritano Hospital - Higienopolis, Sao Paulo, Brazil
15Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
16Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
17Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
18Department of Haematology, Concord Hospital, Concord, NSW, Australia
19University of Modena and Reggio Emilia, University of Modena and Reggio Emilia, Modena, Italy
20CHIMOMO department, Università degli Studi di Modena e Reggio Emilia, Modena, Italy

4:45 PM

Thomas Relander, MD, PhD1*, Martin Bjerregård Pedersen, MD, PhD2*, Fredrik Ellin, MD, PhD1*, Grete Fossum Lauritzsen3*, Esa Jantunen, MD, PhD4*, Hans Hagberg, M.D.5*, Harald Holte, MD, PhD6, Anders Österborg, MD, PhD7, Peter De Nully Brown, MD8, Outi Kuittinen9*, Martin Erlanson, MD, PhD10*, Bjorn Ostenstad, MD, PhD6*, Unn-Merete Fagerli11*, Jan Delabie, MD, PhD12*, Christer Sundström13*, Birgitta Sander, MD, PhD, Prof.14, Stephen Hamilton-Dutoit, MD15*, Mats Ehinger16*, Knut Liestol17*, Helle Toldbod, PhD, MS18*, Andrew L. Feldman, MD19 and Francesco Annibale d'Amore, MD, DMSc20

1Department of Oncology, Skane University Hospital, Lund, Sweden
2Department of Haematology, Aarhus University Hospital, Aarhus, Denmark
3Dept. of Oncology, Oslo University Hospital, Oslo, Norway
4Department of Medicine, Kuopio University Hospital, Kuopio, Finland
5Dept. of Oncology, Uppsala University Hospital, Uppsala, Sweden
6Department of Oncology, Oslo University Hospital, Oslo, Norway
7Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
8Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
9Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland
10Department of Oncology, Norrland University Hospital, Umeå, Sweden
11Department of Oncology, St. Olavs Hospital, Trondheim, Norway
12Department of Pathology, Oslo University Hospital, Oslo, Norway
13Department of Pathology, Uppsala Academic Hospital, Uppsala, Sweden
14Center of Pathology, Karolinska University Hospital, Stockholm, Sweden
15Department of Pathology, Aarhus University Hospital, Aarhus, Denmark
16Department of Oncology and Pathology, Lund University Hospital, Lund, Sweden
17Dept. of Informatics, University of Oslo, Oslo, Norway
18Department of Hematology, Aarhus University Hospital, Aarhus, Denmark, Denmark
19Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
20Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

5:00 PM

Rahul S. Bhansali, MD1,2, Fredrik Ellin, MD, PhD3*, Miao Cao1,2*, Thomas Relander, MD, PhD4*, Wenrui Li, PhD5*, Qi Long, PhD5*, Nivetha Ganesan, MPH6*, Robert Stuver, MD6, Steven M. Horwitz, MD6, Kitsada Wudhikarn, MD7, Steven R Hwang, MD7, N. Nora Nora Bennani, MD7, Julio C. Chavez, MD8, Lubomir Sokol, MD, PhD8, Hayder Saeed, MD8, Frank Duan9*, Pierluigi Porcu, MD10, Priyanka Pullarkat11, Neha Mehta-Shah, MD, MSCI12, Jasmine Zain, MD13, Miguel Ruiz, MD14*, Jonathan E Brammer, MD15, Rishab Prakash, BS16*, Swami P. Iyer, MD16, Adam J. Olszewski, MD17, Ajay Major, MD, MBA18,19, Sonali M. Smith, MD20, Peter A. Riedell, MD21, Caroline Goldin, MD22*, Bradley M. Haverkos, MD, MS, MPH22, Bei Hu, MD23, Pamela B. Allen, MD24, Wael Toama, MD25, Murali Janakiram, MD, MS25, Taylor Brooks, MD26, Deepa Jagadeesh, MD27, Nisha Hariharan, MD28*, Aaron M Goodman28, Paola Ghione, MD29, Fatima Fayyaz, MBBS30*, Joanna M. Rhodes, MD, MSCE30, Elise A. Chong, MD2,31, James N. Gerson, MD1,32, Daniel J. Landsburg, MD2,31, Sunita Dwivedy Nasta, MD1,2, Stephen J. Schuster, MD1,2, Jakub Svoboda, MD1,2, Mats Jerkeman, MD, PhD33 and Stefan K. Barta, MD1,2

1Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
2Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
3Department of Internal Medicine, Kalmar County Hospital, Kalmar, Sweden
4Department of Oncology, Skane University Hospital, Lund, Sweden
5Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA
6Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Division of Hematology, Mayo Clinic, Rochester, MN
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9Division of Hematologic Malignancies, Thomas Jefferson University, Philadelphia, PA
10Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
11Washington University in St. Louis, Department of Medicine, Division of Hematology/Oncology, St. Louis, MO
12Division of Oncology, Washington University School of Medicine, St. Louis, MO
13City of Hope Comprehensive Cancer Center, Duarte, CA
14Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
15Division of Hematology, Department of Internal Medicine, The Ohio State University James Comprehensive Cancer Center, Columbus, OH
16The University of Texas MD Anderson Cancer Center, Houston, TX
17Division of Hematology/Oncology, Brown University, Providence, RI
18The University of Chicago Comprehensive Cancer Center, Denver, CO
19University of Colorado School of Medicine, Denver, CO
20Comprehensive Cancer Center, University of Chicago, Chicago, IL
21The University of Chicago Comprehensive Cancer Center, Chicago, IL
22University of Colorado Cancer Center, Denver, CO
23Levine Cancer Institute, Atrium Health, Charlotte, NC
24Department of Hematology, Emory University School of Medicine, Decatur, GA
25University of Minnesota, Minneapolis, MN
26Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
27Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
28University of California San Diego Moores Cancer Center, San Diego, CA
29Roswell Park Comprehensive Cancer Center, New York, NY
30Northwell Health Cancer Institute, New Hyde Park, NY
31Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
32Lymphoma Program, Abramson Cancer Center, Philadelphia, PA
33Skane University Hospital and Lund University, Lund, Skaane Laen, Sweden

5:15 PM

Kamel Laribi, MD1*, Loic Ysebaert, MD, PhD2*, Luca Inchiappa, MD3*, Bruno Villemagne, MD4*, Yann Guillermin, MD5*, Jérôme Paillassa, MD6*, Fatiha Merabet, MD7*, Cécile Guénot, PharmD8*, Alix Baugier de Materre, MD9*, Charles Herbaux10, Kristell Mahe, MD11*, Marion Divoux, MD12*, Caroline Algrin13*, Stephane Lepretre, MD14*, Damien Roos Weil, MD, PhD15*, Cécile Tomowiak, MD16*, David Ghez, MD, PhD17*, Stéphanie Poulain, MD, PhD18*, Marion Loirat, MD19*, Caroline Dartigeas, MD20*, Lise Willems, MD21*, Olivier Tournilhac, MD, PhD22* and Marie C Bene, PharmD, DPhil23*

1Hématologie clinique, CH Le Mans, Le Mans, France
2Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
3Hematology Department, Institut Paoli-Calmettes, Marseille, France
4Clinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
5Hematology Department, Centre Léon Bérard, Lyon, France
6CHU Angers, Hematology, Angers, France
7Department of Hematology, CH Versailles, Le Chesnay, France
8Centre Hospitalier du Mans, Le Mans, France
9CLINEA CRF Port Royal, Paris, France
10Hematology Department, Montpellier University Hospital, Montpellier, France, Montpellier, France
11Centre Hospitalier de Quimper, QUIMPER CEDEX, FRA
12Hematology Department, Nancy University Hospital, Vandoeuvre, France
13Institut Daniel Hollard, Grenoble, France
14Centre Henri Becquerel, Rouen, Rouen, FRA
15Hematology department, Sorbonne Université Hôpital Pitié Salpêtrière APHP, Paris, FRA
16Department of Hematology, CHU Poitiers, Poitiers, France
17Service d'Hématologie, Département de Médecine, Gustave Roussy Cancer Campus, Villejuif, France
18Service d'Hématologie Cellulaire, Centre de Biologie et Pathologie, CHRU de Lille, France/ INSERM UMR-S 1172, IRCL, Lille, FRA
19Clinical Hematology, Centre Hospitalier de Saint-Nazaire, Saint-Nazaire, France
20Department of Hematology and Cellular Therapy, CHRU de Tours, Hôpital Bretonneau, Tours, France
21Department of Hematology, APHP, Hôpital Cochin, Paris, France
22Hématologie Clinique Adulte et Thérapie Cellulaire, CHU Hotel Dieu Hématologie, Clermont-Ferrand, France
23Hematology Biology, Nantes University Hospital, Nantes, France

5:30 PM

Bei Hu, MD1, Shebli Atrash, MD1, Leah Cohen, MD2*, Stefan K. Barta, MD3, Yumeng Zhang, MD4, Lubomir Sokol, MD, PhD5, Amy Ayers, MPH6*, Luis E Malpica Castillo, MD7*, Steven R Hwang, MD8*, N. Nora Nora Bennani, MD8, David Wada, MD9*, Aung M Tun, MD10, Tamara K. Moyo, MD, PhD1*, Nilanjan Ghosh, MD1 and Michi M Shinohara, MD11*

1Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
2Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, PA
3Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
4H. Lee Moffitt Cancer Center and Research Institute, Department of Malignant Hematology, Tampa
5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX
8Division of Hematology, Mayo Clinic, Rochester, MN
9Department of Dermatology, Huntsman Cancer Institute at University of Utah, Salt Lake City, UT
10Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Medical Center, Kansas City, KS
11Department of Dermatology, University of Washington/Fred Hutchinson Cancer Center, Seattle, WA

5:45 PM

Francine M. Foss, MD1,2,3, Youn H. Kim, MD4,5, H. Miles Miles Prince, MD6,7, Timothy M. Kuzel, MD8, Costas K. Yannakou, MBBS9*, Chean Eng Ooi, PhD10*, Dongyuan Xing, PH D10*, Nicholas Sauter, MD10*, Preeti Singh, MD11*, Myron Czuczman, MD12 and Madeleine Duvic, MD13,14

1Yale Cancer Center and Yale School of Medicine, New Haven, CT
2Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
3Yale University School of Medicine, New Haven, CT
4Stanford Cancer Institute/Cutaneous Lymphoma, Stanford University School of Medicine, Palo Alto, CA
5Department of Dermatology, Stanford University School of Medicine, Palo Alto, CA
6Peter MacCallum Cancer Inst., East Melbourne, AUS
7Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
8Rush University Cancer Center, Rush University Medical Center, Chicago, IL
9Epworth HealthCare, Melbourne, VIC, Australia
10Eisai Inc., Nutley, NJ
11Citius Pharmaceuticals Inc., Yardley, PA
12Citius Pharmaceuticals Inc., Cranford, NJ
13MD Anderson Cancer Center, Houston, TX
14The University of Texas M.D. Anderson Cancer Center, Houston, TX

*signifies non-member of ASH